Evidence map›Paper›PMID 36185025›Full record

ArticlePolish journal of microbiology2022

Opportunistic

Mıne Altinkaya Çavuş, Hafıze Sav

Open access · goldAbstract read
In one paragraph

Article in Polish journal of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Risk factors for healthcare-associated candidemia in adults hospitalized with SARS-CoV-2 infection.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  12. Article
  13. Article
  14. The Clinical Characteristics of Bloodstream Infections Due toJournal of fungi (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Lower Concentrations of Amphotericin B Combined withAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mıne Altinkaya ÇavuşDepartment of Intensive Care, University of Health Sciences, Kayseri City Hospital, Kayseri, Turkey.ORCID https://orcid.org/0000-0003-2584-0463
Hafıze SavDepartment of Mycology, University of Health Sciences, Kayseri City Hospital, Kayseri, Turkey.ORCID https://orcid.org/0000-0001-8435-396X
Kayseri Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The frequency of opportunistic fungal infections in critically ill patients whose intensive care unit stays are prolonged due to coronavirus disease 2019 (COVID-19) is higher than in the period before COVID-19. We planned this study to improve the management of

Indexed as

CandidemiaCandidiasisCOVID-19Opportunistic InfectionsUrinary Tract InfectionsAnti-Bacterial AgentsAntifungal AgentsCandidaCritical IllnessHumansRetrospective StudiesRisk FactorsAnti-Bacterial AgentsAntifungal AgentsCOVID-19critical careopportunistic Candida infections

Identifiers

PMID36185025
PMCPMC9608158
OpenAlexW4300427371

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.